10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,043,614 | -5.3% | 98,027 | +28.1% | 0.00% | 0.0% |
| Q2 2023 | $4,271,928 | -5.8% | 76,503 | -5.9% | 0.00% | -33.3% |
| Q1 2023 | $4,536,508 | +42.7% | 81,314 | -6.3% | 0.00% | +50.0% |
| Q4 2022 | $3,178,540 | +15.3% | 86,770 | -5.9% | 0.00% | 0.0% |
| Q3 2022 | $2,756,127 | +44.3% | 92,236 | +122.7% | 0.00% | +100.0% |
| Q2 2022 | $1,910,261 | -20.8% | 41,413 | +28.5% | 0.00% | -50.0% |
| Q1 2022 | $2,412,203 | +704.1% | 32,219 | +1519.9% | 0.00% | – |
| Q4 2021 | $300,000 | +2.7% | 1,989 | -1.0% | 0.00% | – |
| Q3 2021 | $292,000 | -97.7% | 2,009 | -96.9% | 0.00% | -100.0% |
| Q2 2021 | $12,730,000 | +8.9% | 65,011 | +0.7% | 0.01% | 0.0% |
| Q1 2021 | $11,688,000 | +28.1% | 64,574 | +0.2% | 0.01% | +25.0% |
| Q4 2020 | $9,125,000 | +496.4% | 64,442 | +424.9% | 0.01% | +300.0% |
| Q3 2020 | $1,530,000 | – | 12,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |